As of Mar 24
| -0.08 / -0.86%|
The 6 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 16.75, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate represents a +81.87% increase from the last price of 9.21.
The current consensus among 6 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.